Compare MDIA & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDIA | DRIO |
|---|---|---|
| Founded | 2019 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Broadcasting | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.0M | 52.8M |
| IPO Year | 2019 | 2013 |
| Metric | MDIA | DRIO |
|---|---|---|
| Price | $1.04 | $7.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 37.4K | 21.3K |
| Earning Date | 05-19-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | N/A | ★ 1.25 |
| Revenue | ★ $133,336,000.00 | $7,394,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | N/A | $47.58 |
| P/E Ratio | ★ N/A | $5.98 |
| Revenue Growth | 39.52 | ★ 43.02 |
| 52 Week Low | $0.54 | $0.38 |
| 52 Week High | $1.64 | $17.74 |
| Indicator | MDIA | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 54.95 | 53.56 |
| Support Level | $0.57 | $7.18 |
| Resistance Level | $1.64 | $9.24 |
| Average True Range (ATR) | 0.07 | 0.61 |
| MACD | -0.00 | 0.10 |
| Stochastic Oscillator | 58.11 | 64.25 |
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.